Probiotics as Beneficial Dietary Supplements to Prevent and Treat Cardiovascular Diseases: Uncovering Their Impact on Oxidative Stress

@article{Vasquez2019ProbioticsAB,
  title={Probiotics as Beneficial Dietary Supplements to Prevent and Treat Cardiovascular Diseases: Uncovering Their Impact on Oxidative Stress},
  author={E. C. Vasquez and T. M. Pereira and V. Peotta and M. Baldo and M. Campos-Toimil},
  journal={Oxidative Medicine and Cellular Longevity},
  year={2019},
  volume={2019}
}
The gut microbiota, the ecosystem formed by a wide symbiotic community of nonpathogenic microorganisms that are present in the distal part of the human gut, plays a prominent role in the normal physiology of the organism. The gut microbiota's imbalance, gut dysbiosis, is directly related to the origin of various processes of acute or chronic dysfunction in the host. Therefore, the ability to intervene in the gut microbiota is now emerging as a possible tactic for therapeutic intervention in… Expand
Probiotics as Live Bio-therapeutics: Prospects and Perspectives
TLDR
The establishment of probiotic as bio-therapeutics should depend on measurable markers and scientific evidence-based criteria by conducting multidisciplinary research to set up facts and mechanisms of action for selected probiotic strains. Expand
New Insights on the Beneficial Effects of the Probiotic Kefir on Vascular Dysfunction in Cardiovascular and Neurodegenerative Diseases.
TLDR
The focus of the discussion is the endothelial dysfunction that accompanies the hypertension, and the neurovascular dysfunction that characterizes the ageing-related dementia in patients suffering of Alzheimer disease. Expand
Gut Microbiota, Diet, and Chronic Diseases: The Role Played by Oxidative Stress
TLDR
The three terms used in the title of this special issue: gut microbiota, diet, and chronic diseases, that have sounded so discrepant until the last century begin to have a stronger meaning in the present century. Expand
Potential Benefits of Probiotics and Prebiotics for Coronary Heart Disease and Stroke
Among cardiovascular diseases (CVDs), a major cause of morbidity and mortality worldwide, coronary heart disease and stroke are the most well-known and extensively studied. The onset and progressionExpand
Probiotics supplementation and cardiometabolic risk factors: A new insight into recent advances, potential mechanisms, and clinical implications
Abstract Background Subjects who have cardiovascular diseases (CVDs) share a variety of common characteristic including increased blood pressure (BP), disrupted glycemic control, and augmented levelsExpand
The gut microbiome as a target for adjuvant therapy in obstructive sleep apnea
TLDR
There are no clinical trials and only limited evidence from animal studies describing the beneficial effects of pre- and probiotic supplementation on OSA-mediated dysbiosis, so more work is necessary to assess whether prebiotics, probiotics and SCFA are promising future novel strategies for targeting OSA. Expand
Modulatory Effects of Probiotics During Pathogenic Infections With Emphasis on Immune Regulation
TLDR
This review discusses two important aspects of the application of probiotics during pathogenic infections; and their modulatory effects on the immune response of the host during infectious and non-infectious diseases. Expand
Effect of Probiotics Supplementations on Health Status of Athletes
TLDR
Probiotic supplementation improved the intestinal permeability, immune system, intestinal microbiota, inflammatory system, reduced the severity and incidence of respiratory tract infections, and duration of gastrointestinal symptoms and the literature survey summarized the effect of probiotic supplementation on health status of athletes. Expand
Probiotics, Prebiotics and Synbiotics—A Promising Strategy in Prevention and Treatment of Cardiovascular Diseases?
  • B. Olas
  • Medicine
  • International journal of molecular sciences
  • 2020
TLDR
While it cannot be unequivocally stated whether such supplementation yields benefits in the prevention and treatment of CVDs, it is important to note that clinical studies performed to date have not identified any side-effects to use, and further experimental research is needed before these substances can be used in the Prevention and treatmentof CVD. Expand
Oxidative stress tolerance and antioxidant capacity of lactic acid bacteria as probiotic: a systematic review
TLDR
The aim of the present review is to provide an overview of the current state of the research associated with the oxidative stress tolerance and antioxidant capacity of LAB. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 91 REFERENCES
Mechanisms of Action of Kefir in Chronic Cardiovascular and Metabolic Diseases
TLDR
Interestingly, recent studies show that mechanisms of actions of kefir in cardiometabolic diseases include recruitment of endothelial progenitor cells, improvement of the balance vagal/sympathetic nervous system, diminution of excessive generation of reactive oxygen species and alteration of the intestinal microbiota. Expand
Gut microbiota imbalance and chaperoning system malfunction are central to ulcerative colitis pathogenesis and can be counteracted with specifically designed probiotics: a working hypothesis
TLDR
For further studies of the physiopathology and treatment for inflammatory bowel diseases, an integral view of the conditions, including the triad of microbiota–heat shock proteins (HSPs)–probiotics, ought to be considered and efforts are necessary to develop diagnostic tools for elucidating levels and distribution of HSPs and the microbiota composition (microbiota fingerprint) of each subject. Expand
The role of intestinal microbiota in cardiovascular disease
TLDR
The role of gut microbiota in the pathogenesis of CVDs, including coronary artery disease, hypertension and heart failure, is summarized to provide valuable insights into potential therapeutic strategies for CVD that involve interfering with the composition, function and metabolites of the intestinal flora. Expand
Intersections Between Microbiome and Heart Failure: Revisiting the Gut Hypothesis.
Microbes play an important role in human health and disease. In the setting of heart failure (HF), substantial hemodynamic changes, such as hypoperfusion and congestion in the intestines, can alterExpand
Gut microbiota: next frontier in understanding human health and development of biotherapeutics
TLDR
The human gut microbiota is a legitimate therapeutic target to treat and/or prevent various diseases and can be exploited in development of biotherapeutics. Expand
Antihypertensive Effects of Probiotics
TLDR
Further investigations are needed to clarify if the effects of probiotic bacteria result from the changes in the gut microbiota and its metabolic by-products; the restoration of the gut barrier function; and the effects on endotoxemia, inflammation, and renal sympathetic nerve activity. Expand
Gut microbiota and hypertension: From pathogenesis to new therapeutic strategies.
TLDR
The role of gut microbiota in hypertension progression, and probiotics in the treatment of hypertension are summarized. Expand
Current Perspectives on Antihypertensive Probiotics
TLDR
The antihypertensive roles of probiotics and their fermented products via the reduction of serum cholesterol levels, anti-inflammation, and inhibition of angiotensin-converting enzyme are discussed. Expand
Dietary metabolism, the gut microbiome, and heart failure
TLDR
Findings suggest that the gut microbiome functions like an endocrine organ by generating bioactive metabolites that can directly or indirectly affect host physiology, and novel therapeutic strategies targeting gut microbial metabolic pathways and/or metabolites have the potential to modulate cardiovascular disease susceptibility and prevent progression to HF. Expand
Exploring the Microbiome in Heart Failure
TLDR
Dysbiosis of gut microbiota can contribute to higher levels of TMAO and the generation of uremic toxins, progressing to both HF and CKD, therefore, this bidirectional relationship between HF and chronic kidney disease through gut microbiota may be a novel therapeutic target for the cardiorenal syndrome. Expand
...
1
2
3
4
5
...